NEW YORK (Web Desk) – A US jury has Johnson & Johnson to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer. The verdict, which J&J
NEW YORK (Web Desk) – A US jury has Johnson & Johnson to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer.
The verdict, which J&J plans to appeal, was the second straight trial loss for the company, which is facing about 1,200 lawsuits accusing the company of not adequately warning consumers about its talc-based products’ cancer risks.
Following a three-week trial in Missouri state court, jurors deliberated for about a day before giving a verdict for Gloria Ristesund.
She was awarded $5 million in compensatory damages and $50 million in punitive damages.
J&J spokeswoman Carol Goodrich said the verdict contradicted 30 years of research supporting the safety of cosmetic talc. The company intends to appeal and will keep defending its products’ safety, she said.
Ristesund said she used J&J’s talc-based powder products – which include the well-known Baby Powder and Shower to Shower Powder – on her genitals for decades. According to her lawyers, she was diagnosed with ovarian cancer and had to undergo a hysterectomy and related surgeries. Her cancer is now in remission.
Jere Beasley, whose firm represents Ristesund, said his client was gratified with the verdict. The jury’s decision should “end the litigation” and compel J&J to settle the remaining cases, he said.